Company intelligence / Profile preview

Mahogany Acquisition

Jackson, Mississippi, USA

Ownership: Private
Development stage: Other

Overview

Mahogany Acquisition Corp. is a blank check company, also known as a special purpose acquisition company (SPAC), formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination. The company specifically targets businesses within the healthcare industry, with a particular focus on the oncology and diabetes sectors. Mahogany Acquisition aims to leverage the expertise of its management team to identify and scale high-growth companies that provide innovative clinical and diagnostic solutions. In 2024, the company announced a definitive merger agreement with Arisun Therapeutics, a biotechnology firm focused on developing therapies for metabolic diseases and cancer.

Industry: Investors

Partnerships

Arisun Therapeutics

Beyond the preview

Go deeper on Mahogany Acquisition.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mahogany Acquisition.

Explore the full profile